Oncology

A patient says the pain is manageable. The medication chart looks stable. The latest score is not alarming. Then, sometime before the next formal reassessment, the pain breaks through. That is the operational problem behind Zhuang et al.’s study on predicting lung-cancer pain episodes with a hybrid machine-learning and large-language-model pipeline.1 The paper is not really about whether “AI can predict pain,” a sentence that sounds impressive until one remembers that dashboards have been predicting things since before consultants discovered the word “agentic.” The more interesting question is narrower and more useful: when should a hospital trust structured data, and when should it ask a language model to read the messy clinical story around the data? ...

Report First, Diagnosis Second A medical report usually arrives after the diagnostic work is done. It explains, records, justifies, and sometimes politely hides how messy the evidence really was. This paper asks a more interesting question: what if the report itself becomes a predictive object? In Multimodal Oncology Agent for IDH1 Mutation Prediction in Low-Grade Glioma, Hafsa Akebli and colleagues build a Multimodal Oncology Agent, or MOA, for predicting IDH1 mutation status in low-grade glioma using TCGA-LGG data, whole-slide histology, structured clinical variables, genomic context, and external biomedical knowledge sources.1 The immediate headline is easy enough: the full multimodal setup reaches the best reported performance, with an F1-score of 0.912. ...